Global Retinal Biologics Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Retinal Biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Retinal Biologics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Retinal Biologics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Macular Degeneration segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Retinal Biologics include Spark Therapeutics, Inc, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc, AbbVie Inc, and Johnson & Johnson Services, Inc, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Retinal Biologics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Macular Degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others
Market segment by Application, can be divided into
Hospitals
Clinics
Others
Market segment by players, this report covers
Spark Therapeutics, Inc
F. Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals, Inc
AbbVie Inc
Johnson & Johnson Services, Inc
Amgen Inc
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Retinal Biologics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Retinal Biologics, with revenue, gross margin and global market share of Retinal Biologics from 2019 to 2022.
Chapter 3, the Retinal Biologics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Retinal Biologics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Retinal Biologics research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Retinal Biologics
1.2 Classification of Retinal Biologics by Type
1.2.1 Overview: Global Retinal Biologics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Retinal Biologics Revenue Market Share by Type in 2021
1.2.3 Macular Degeneration
1.2.4 Diabetic Retinopathy
1.2.5 Diabetic Macular Edema
1.2.6 Uveitis
1.2.7 Others
1.3 Global Retinal Biologics Market by Application
1.3.1 Overview: Global Retinal Biologics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Retinal Biologics Market Size & Forecast
1.5 Global Retinal Biologics Market Size and Forecast by Region
1.5.1 Global Retinal Biologics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Retinal Biologics Market Size by Region, (2017-2022)
1.5.3 North America Retinal Biologics Market Size and Prospect (2017-2028)
1.5.4 Europe Retinal Biologics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Retinal Biologics Market Size and Prospect (2017-2028)
1.5.6 South America Retinal Biologics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Retinal Biologics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Retinal Biologics Market Drivers
1.6.2 Retinal Biologics Market Restraints
1.6.3 Retinal Biologics Trends Analysis
2 Company Profiles
2.1 Spark Therapeutics, Inc
2.1.1 Spark Therapeutics, Inc Details
2.1.2 Spark Therapeutics, Inc Major Business
2.1.3 Spark Therapeutics, Inc Retinal Biologics Product and Solutions
2.1.4 Spark Therapeutics, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Spark Therapeutics, Inc Recent Developments and Future Plans
2.2 F. Hoffmann-La Roche Ltd
2.2.1 F. Hoffmann-La Roche Ltd Details
2.2.2 F. Hoffmann-La Roche Ltd Major Business
2.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Product and Solutions
2.2.4 F. Hoffmann-La Roche Ltd Retinal Biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.3 Regeneron Pharmaceuticals, Inc
2.3.1 Regeneron Pharmaceuticals, Inc Details
2.3.2 Regeneron Pharmaceuticals, Inc Major Business
2.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Product and Solutions
2.3.4 Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Regeneron Pharmaceuticals, Inc Recent Developments and Future Plans
2.4 AbbVie Inc
2.4.1 AbbVie Inc Details
2.4.2 AbbVie Inc Major Business
2.4.3 AbbVie Inc Retinal Biologics Product and Solutions
2.4.4 AbbVie Inc Retinal Biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 AbbVie Inc Recent Developments and Future Plans
2.5 Johnson & Johnson Services, Inc
2.5.1 Johnson & Johnson Services, Inc Details
2.5.2 Johnson & Johnson Services, Inc Major Business
2.5.3 Johnson & Johnson Services, Inc Retinal Biologics Product and Solutions
2.5.4 Johnson & Johnson Services, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Johnson & Johnson Services, Inc Recent Developments and Future Plans
2.6 Amgen Inc
2.6.1 Amgen Inc Details
2.6.2 Amgen Inc Major Business
2.6.3 Amgen Inc Retinal Biologics Product and Solutions
2.6.4 Amgen Inc Retinal Biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Amgen Inc Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Retinal Biologics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Retinal Biologics Players Market Share in 2021
3.2.2 Top 10 Retinal Biologics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Retinal Biologics Players Head Office, Products and Services Provided
3.4 Retinal Biologics Mergers & Acquisitions
3.5 Retinal Biologics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Retinal Biologics Revenue and Market Share by Type (2017-2022)
4.2 Global Retinal Biologics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Retinal Biologics Revenue Market Share by Application (2017-2022)
5.2 Global Retinal Biologics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Retinal Biologics Revenue by Type (2017-2028)
6.2 North America Retinal Biologics Revenue by Application (2017-2028)
6.3 North America Retinal Biologics Market Size by Country
6.3.1 North America Retinal Biologics Revenue by Country (2017-2028)
6.3.2 United States Retinal Biologics Market Size and Forecast (2017-2028)
6.3.3 Canada Retinal Biologics Market Size and Forecast (2017-2028)
6.3.4 Mexico Retinal Biologics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Retinal Biologics Revenue by Type (2017-2028)
7.2 Europe Retinal Biologics Revenue by Application (2017-2028)
7.3 Europe Retinal Biologics Market Size by Country
7.3.1 Europe Retinal Biologics Revenue by Country (2017-2028)
7.3.2 Germany Retinal Biologics Market Size and Forecast (2017-2028)
7.3.3 France Retinal Biologics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Retinal Biologics Market Size and Forecast (2017-2028)
7.3.5 Russia Retinal Biologics Market Size and Forecast (2017-2028)
7.3.6 Italy Retinal Biologics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Retinal Biologics Revenue by Type (2017-2028)
8.2 Asia-Pacific Retinal Biologics Revenue by Application (2017-2028)
8.3 Asia-Pacific Retinal Biologics Market Size by Region
8.3.1 Asia-Pacific Retinal Biologics Revenue by Region (2017-2028)
8.3.2 China Retinal Biologics Market Size and Forecast (2017-2028)
8.3.3 Japan Retinal Biologics Market Size and Forecast (2017-2028)
8.3.4 South Korea Retinal Biologics Market Size and Forecast (2017-2028)
8.3.5 India Retinal Biologics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Retinal Biologics Market Size and Forecast (2017-2028)
8.3.7 Australia Retinal Biologics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Retinal Biologics Revenue by Type (2017-2028)
9.2 South America Retinal Biologics Revenue by Application (2017-2028)
9.3 South America Retinal Biologics Market Size by Country
9.3.1 South America Retinal Biologics Revenue by Country (2017-2028)
9.3.2 Brazil Retinal Biologics Market Size and Forecast (2017-2028)
9.3.3 Argentina Retinal Biologics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Retinal Biologics Revenue by Type (2017-2028)
10.2 Middle East & Africa Retinal Biologics Revenue by Application (2017-2028)
10.3 Middle East & Africa Retinal Biologics Market Size by Country
10.3.1 Middle East & Africa Retinal Biologics Revenue by Country (2017-2028)
10.3.2 Turkey Retinal Biologics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Retinal Biologics Market Size and Forecast (2017-2028)
10.3.4 UAE Retinal Biologics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Retinal Biologics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Retinal Biologics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Retinal Biologics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Retinal Biologics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Retinal Biologics Revenue Market Share by Region (2023-2028)
Table 6. Spark Therapeutics, Inc Corporate Information, Head Office, and Major Competitors
Table 7. Spark Therapeutics, Inc Major Business
Table 8. Spark Therapeutics, Inc Retinal Biologics Product and Solutions
Table 9. Spark Therapeutics, Inc Retinal Biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. F. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors
Table 11. F. Hoffmann-La Roche Ltd Major Business
Table 12. F. Hoffmann-La Roche Ltd Retinal Biologics Product and Solutions
Table 13. F. Hoffmann-La Roche Ltd Retinal Biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Regeneron Pharmaceuticals, Inc Corporate Information, Head Office, and Major Competitors
Table 15. Regeneron Pharmaceuticals, Inc Major Business
Table 16. Regeneron Pharmaceuticals, Inc Retinal Biologics Product and Solutions
Table 17. Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. AbbVie Inc Corporate Information, Head Office, and Major Competitors
Table 19. AbbVie Inc Major Business
Table 20. AbbVie Inc Retinal Biologics Product and Solutions
Table 21. AbbVie Inc Retinal Biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Johnson & Johnson Services, Inc Corporate Information, Head Office, and Major Competitors
Table 23. Johnson & Johnson Services, Inc Major Business
Table 24. Johnson & Johnson Services, Inc Retinal Biologics Product and Solutions
Table 25. Johnson & Johnson Services, Inc Retinal Biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Amgen Inc Corporate Information, Head Office, and Major Competitors
Table 27. Amgen Inc Major Business
Table 28. Amgen Inc Retinal Biologics Product and Solutions
Table 29. Amgen Inc Retinal Biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Global Retinal Biologics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 31. Global Retinal Biologics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 32. Breakdown of Retinal Biologics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Retinal Biologics Players Head Office, Products and Services Provided
Table 34. Retinal Biologics Mergers & Acquisitions in the Past Five Years
Table 35. Retinal Biologics New Entrants and Expansion Plans
Table 36. Global Retinal Biologics Revenue (USD Million) by Type (2017-2022)
Table 37. Global Retinal Biologics Revenue Share by Type (2017-2022)
Table 38. Global Retinal Biologics Revenue Forecast by Type (2023-2028)
Table 39. Global Retinal Biologics Revenue by Application (2017-2022)
Table 40. Global Retinal Biologics Revenue Forecast by Application (2023-2028)
Table 41. North America Retinal Biologics Revenue by Type (2017-2022) & (USD Million)
Table 42. North America Retinal Biologics Revenue by Type (2023-2028) & (USD Million)
Table 43. North America Retinal Biologics Revenue by Application (2017-2022) & (USD Million)
Table 44. North America Retinal Biologics Revenue by Application (2023-2028) & (USD Million)
Table 45. North America Retinal Biologics Revenue by Country (2017-2022) & (USD Million)
Table 46. North America Retinal Biologics Revenue by Country (2023-2028) & (USD Million)
Table 47. Europe Retinal Biologics Revenue by Type (2017-2022) & (USD Million)
Table 48. Europe Retinal Biologics Revenue by Type (2023-2028) & (USD Million)
Table 49. Europe Retinal Biologics Revenue by Application (2017-2022) & (USD Million)
Table 50. Europe Retinal Biologics Revenue by Application (2023-2028) & (USD Million)
Table 51. Europe Retinal Biologics Revenue by Country (2017-2022) & (USD Million)
Table 52. Europe Retinal Biologics Revenue by Country (2023-2028) & (USD Million)
Table 53. Asia-Pacific Retinal Biologics Revenue by Type (2017-2022) & (USD Million)
Table 54. Asia-Pacific Retinal Biologics Revenue by Type (2023-2028) & (USD Million)
Table 55. Asia-Pacific Retinal Biologics Revenue by Application (2017-2022) & (USD Million)
Table 56. Asia-Pacific Retinal Biologics Revenue by Application (2023-2028) & (USD Million)
Table 57. Asia-Pacific Retinal Biologics Revenue by Region (2017-2022) & (USD Million)
Table 58. Asia-Pacific Retinal Biologics Revenue by Region (2023-2028) & (USD Million)
Table 59. South America Retinal Biologics Revenue by Type (2017-2022) & (USD Million)
Table 60. South America Retinal Biologics Revenue by Type (2023-2028) & (USD Million)
Table 61. South America Retinal Biologics Revenue by Application (2017-2022) & (USD Million)
Table 62. South America Retinal Biologics Revenue by Application (2023-2028) & (USD Million)
Table 63. South America Retinal Biologics Revenue by Country (2017-2022) & (USD Million)
Table 64. South America Retinal Biologics Revenue by Country (2023-2028) & (USD Million)
Table 65. Middle East & Africa Retinal Biologics Revenue by Type (2017-2022) & (USD Million)
Table 66. Middle East & Africa Retinal Biologics Revenue by Type (2023-2028) & (USD Million)
Table 67. Middle East & Africa Retinal Biologics Revenue by Application (2017-2022) & (USD Million)
Table 68. Middle East & Africa Retinal Biologics Revenue by Application (2023-2028) & (USD Million)
Table 69. Middle East & Africa Retinal Biologics Revenue by Country (2017-2022) & (USD Million)
Table 70. Middle East & Africa Retinal Biologics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Retinal Biologics Picture
Figure 2. Global Retinal Biologics Revenue Market Share by Type in 2021
Figure 3. Macular Degeneration
Figure 4. Diabetic Retinopathy
Figure 5. Diabetic Macular Edema
Figure 6. Uveitis
Figure 7. Others
Figure 8. Retinal Biologics Revenue Market Share by Application in 2021
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Others Picture
Figure 12. Global Retinal Biologics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Retinal Biologics Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Retinal Biologics Revenue Market Share by Region (2017-2028)
Figure 15. Global Retinal Biologics Revenue Market Share by Region in 2021
Figure 16. North America Retinal Biologics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Retinal Biologics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Retinal Biologics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Retinal Biologics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Retinal Biologics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Retinal Biologics Market Drivers
Figure 22. Retinal Biologics Market Restraints
Figure 23. Retinal Biologics Market Trends
Figure 24. Spark Therapeutics, Inc Recent Developments and Future Plans
Figure 25. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Figure 26. Regeneron Pharmaceuticals, Inc Recent Developments and Future Plans
Figure 27. AbbVie Inc Recent Developments and Future Plans
Figure 28. Johnson & Johnson Services, Inc Recent Developments and Future Plans
Figure 29. Amgen Inc Recent Developments and Future Plans
Figure 30. Global Retinal Biologics Revenue Share by Players in 2021
Figure 31. Retinal Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 32. Global Top 3 Players Retinal Biologics Revenue Market Share in 2021
Figure 33. Global Top 10 Players Retinal Biologics Revenue Market Share in 2021
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 35. Global Retinal Biologics Revenue Share by Type in 2021
Figure 36. Global Retinal Biologics Market Share Forecast by Type (2023-2028)
Figure 37. Global Retinal Biologics Revenue Share by Application in 2021
Figure 38. Global Retinal Biologics Market Share Forecast by Application (2023-2028)
Figure 39. North America Retinal Biologics Sales Market Share by Type (2017-2028)
Figure 40. North America Retinal Biologics Sales Market Share by Application (2017-2028)
Figure 41. North America Retinal Biologics Revenue Market Share by Country (2017-2028)
Figure 42. United States Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Retinal Biologics Sales Market Share by Type (2017-2028)
Figure 46. Europe Retinal Biologics Sales Market Share by Application (2017-2028)
Figure 47. Europe Retinal Biologics Revenue Market Share by Country (2017-2028)
Figure 48. Germany Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Retinal Biologics Sales Market Share by Type (2017-2028)
Figure 54. Asia-Pacific Retinal Biologics Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Retinal Biologics Revenue Market Share by Region (2017-2028)
Figure 56. China Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. South Korea Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Retinal Biologics Sales Market Share by Type (2017-2028)
Figure 63. South America Retinal Biologics Sales Market Share by Application (2017-2028)
Figure 64. South America Retinal Biologics Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East and Africa Retinal Biologics Sales Market Share by Type (2017-2028)
Figure 68. Middle East and Africa Retinal Biologics Sales Market Share by Application (2017-2028)
Figure 69. Middle East and Africa Retinal Biologics Revenue Market Share by Country (2017-2028)
Figure 70. Turkey Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. UAE Retinal Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
